SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-101017
Filing Date
2022-04-11
Accepted
2022-04-11 08:07:02
Documents
14
Period of Report
2022-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d352125d8k.htm   iXBRL 8-K 32905
2 EX-99.1 d352125dex991.htm EX-99.1 15083
6 GRAPHIC g352125g0411070801035.jpg GRAPHIC 3507
  Complete submission text file 0001193125-22-101017.txt   183945

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cris-20220411.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20220411_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20220411_pre.xml EX-101.PRE 11250
8 EXTRACTED XBRL INSTANCE DOCUMENT d352125d8k_htm.xml XML 3398
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 22818518
SIC: 2836 Biological Products, (No Diagnostic Substances)